Seeing Is Believing
Checkpoint Therapeutics's activity chart (see below) currently has 10 price targets and 20 ratings on display.
Analysts average stock forecasts to be materialized ratio is 30.48% with an average time for these price targets to be met of 49.71 days.
Most recent stock forecast was given by from D. BORAL CAPITAL on 31-Mar-2025. First documented stock forecast 29-May-2019.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 13-Jan-2025
$4.8
$0.54 (12.68%)
$4.8
1 years 5 months 13 days ago
(31-Mar-2025)
0/3 (0%)
$0.76 (18.81%)
Buy Since 13-Aug-2024
$4.1
$-0.16 (-3.76%)
1 years 6 months 2 days ago
(11-Mar-2025)
1/2 (50%)
$0.1 (2.50%)
45
Buy Since 29-May-2019
$4.1
$-0.16 (-3.76%)
$7
1 years 6 months 3 days ago
(10-Mar-2025)
2/5 (40%)
$0.12 (3.02%)
117
Buy Since 26-Jan-2022
3 years 29 days ago
(15-Aug-2023)
1/3 (33.33%)
$8.34 (125.23%)
24
What is CKPT (Checkpoint Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on CKPT (Checkpoint Therapeutics)?
Which analyst has the most public recommendations on CKPT (Checkpoint Therapeutics)?
Which analyst is the currently most bullish on CKPT (Checkpoint Therapeutics)?
Which analyst is the currently most reserved on CKPT (Checkpoint Therapeutics)?